AI

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

AI

A step towards AI-based precision medicine

Jim Cornall - October 16, 2023

AI

Business and artificial intelligence – how can we prepare for the ‘fourth’ industrial revolution?

admin - October 2, 2023

AI

FlowGPT Hackathon to focus on AI creativity and ethics

Jim Cornall - September 7, 2023

AI

Ibex raises $55m to drive global adoption of AI for cancer diagnosis

Jim Cornall - September 7, 2023

AI

How AI can help dentists with early detection of tooth decay

Jim Cornall - August 8, 2023

AI

AI-enhanced productivity in the workspace

Jim Cornall - August 7, 2023

AI

BioMap unveils Life Science Leaderboard to compare AI models

Jim Cornall - August 7, 2023

1...5 67Page 7 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0